According to the Zhitong Finance App, Pharmaceutical E-Buy (300937.SZ) announcement. The previous announcement revealed that the company plans to establish Sichuan Pharmaceutical E-Buy Technology Group Co., Ltd. Currently, due to policy changes, the company and its wholly-owned subsidiary Chengdu Heshengyi Technology Co., Ltd. will jointly increase the capital of the company's existing wholly-owned subsidiary, Chengdu Pharmaceutical E-Commerce Co., Ltd. (“Chengdu Pharmaceutical E-Commerce”), and change its name to Sichuan Pharmaceutical E-Shop Technology Group Co., Ltd. (subject to the final review of industry and commerce), not to establish a new one, and carry out unified management and equity optimization of related equity projects that the company has already invested in.

In addition, the company plans to establish a wholly-owned subsidiary, Henan Hezong Pharmaceutical World Pharmaceutical Co., Ltd. (“Henan Hezong Pharmaceutical”) in Zhengzhou, Henan Province, with its own capital. In the future, it will strengthen territorial team building and network layout based on the stock business market in Henan and surrounding provinces, and actively expand into Henan and surrounding provinces (Hebei, Shanxi, Shaanxi, Hubei, Jiangsu, Shandong, Anhui, etc.) to become the company's northern regional development center.